IL215388A0 - Process for the preparation of 4-(3-chloro-2-fluoro-anilino)-7-methoxy-6-[1-(n-methylcarbamoylmethyl)-piperidin-4-yl]quinazoline - Google Patents
Process for the preparation of 4-(3-chloro-2-fluoro-anilino)-7-methoxy-6-[1-(n-methylcarbamoylmethyl)-piperidin-4-yl]quinazolineInfo
- Publication number
- IL215388A0 IL215388A0 IL215388A IL21538811A IL215388A0 IL 215388 A0 IL215388 A0 IL 215388A0 IL 215388 A IL215388 A IL 215388A IL 21538811 A IL21538811 A IL 21538811A IL 215388 A0 IL215388 A0 IL 215388A0
- Authority
- IL
- Israel
- Prior art keywords
- methylcarbamoylmethyl
- anilino
- quinazoline
- piperidin
- fluoro
- Prior art date
Links
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/12—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17199409P | 2009-04-23 | 2009-04-23 | |
| PCT/GB2010/050653 WO2010122340A2 (en) | 2009-04-23 | 2010-04-22 | Process 738 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL215388A0 true IL215388A0 (en) | 2011-12-29 |
Family
ID=42224659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL215388A IL215388A0 (en) | 2009-04-23 | 2011-09-26 | Process for the preparation of 4-(3-chloro-2-fluoro-anilino)-7-methoxy-6-[1-(n-methylcarbamoylmethyl)-piperidin-4-yl]quinazoline |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101272613B1 (ko) * | 2011-10-05 | 2013-06-10 | 한미사이언스 주식회사 | 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온 염산염의 제조 방법 및 이에 사용되는 중간체 |
| CN108503596A (zh) * | 2018-03-14 | 2018-09-07 | 盐城师范学院 | 一种新的厄洛替尼及其中间体的制备方法 |
| CN108440420A (zh) * | 2018-03-22 | 2018-08-24 | 盐城师范学院 | 酪氨酸激酶抑制剂拉帕替尼及其关键中间体的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200813014A (en) | 2002-03-28 | 2008-03-16 | Astrazeneca Ab | Quinazoline derivatives |
| US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| GB0320793D0 (en) * | 2003-09-05 | 2003-10-08 | Astrazeneca Ab | Chemical process |
| BRPI0414532B1 (pt) * | 2003-09-19 | 2018-06-05 | Astrazeneca Ab | Composto derivado de quinazolina, processo para preparar 0 mesmo, composição farmaceutica, e, uso de um composto derivado de quinazolina |
| WO2005115145A2 (en) * | 2004-05-20 | 2005-12-08 | Wyeth | Quinone substituted quinazoline and quinoline kinase inhibitors |
| WO2009138779A1 (en) * | 2008-05-13 | 2009-11-19 | Astrazeneca Ab | Combination comprising 4- (3-chloro-2-fluoroanilino) -7-meth0xy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxyjquinazoline |
| MX2010012442A (es) * | 2008-05-13 | 2011-10-11 | Astrazeneca Ab | Sal de fumarato de 4-(3-cloro-2-fluoroanilino)-7-metoxi-6-{[1-(n-m etilcarbamoilmetil) piperidin-4-il]oxi}quinazolina. |
-
2010
- 2010-04-22 CN CN2010800288080A patent/CN102459174A/zh active Pending
- 2010-04-22 KR KR1020117027878A patent/KR20120007059A/ko not_active Withdrawn
- 2010-04-22 BR BRPI1013854A patent/BRPI1013854A2/pt not_active IP Right Cessation
- 2010-04-22 AU AU2010240717A patent/AU2010240717A1/en not_active Abandoned
- 2010-04-22 JP JP2012506579A patent/JP2012524769A/ja active Pending
- 2010-04-22 SG SG2011068426A patent/SG174893A1/en unknown
- 2010-04-22 EP EP10715333A patent/EP2421827A2/en not_active Withdrawn
- 2010-04-22 MX MX2011011177A patent/MX2011011177A/es not_active Application Discontinuation
- 2010-04-22 CA CA2758610A patent/CA2758610A1/en not_active Abandoned
- 2010-04-22 US US13/264,217 patent/US8450482B2/en not_active Expired - Fee Related
- 2010-04-22 WO PCT/GB2010/050653 patent/WO2010122340A2/en not_active Ceased
- 2010-04-23 AR ARP100101374A patent/AR076407A1/es not_active Application Discontinuation
- 2010-04-23 TW TW099112893A patent/TW201041871A/zh unknown
-
2011
- 2011-09-26 IL IL215388A patent/IL215388A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2758610A1 (en) | 2010-10-28 |
| JP2012524769A (ja) | 2012-10-18 |
| WO2010122340A2 (en) | 2010-10-28 |
| US8450482B2 (en) | 2013-05-28 |
| AR076407A1 (es) | 2011-06-08 |
| MX2011011177A (es) | 2011-11-18 |
| KR20120007059A (ko) | 2012-01-19 |
| WO2010122340A3 (en) | 2011-09-09 |
| CN102459174A (zh) | 2012-05-16 |
| WO2010122340A8 (en) | 2011-12-15 |
| SG174893A1 (en) | 2011-11-28 |
| EP2421827A2 (en) | 2012-02-29 |
| US20120108814A1 (en) | 2012-05-03 |
| BRPI1013854A2 (pt) | 2017-05-16 |
| TW201041871A (en) | 2010-12-01 |
| AU2010240717A1 (en) | 2011-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201204467B (en) | Substituted isoquinolinones and quinazolinones | |
| AP3210A (en) | Pyrazolyt quinazoline kinase inhibitors | |
| IL218555A0 (en) | Pi3 kinase inhibitors and uses thereof | |
| IL220212A0 (en) | Aminopyrimidine kinase inhibitors | |
| EP2167092A4 (en) | QUINAZOLINE DERIVATIVES AS INHIBITORS OF PI3 KINASE | |
| ZA201204246B (en) | Kinase inhibitors | |
| ZA201203842B (en) | Kinase inhibitors | |
| SI2491037T1 (sl) | Derivati kinazolin-4(3H)-ona uporabljeni kot inhibitorji PI3 kinaze | |
| IL211549A0 (en) | Aminotriazolopyridines and their use as kinase inhibitors | |
| IL206544A0 (en) | Methods of preparing quinazolinone derivatives | |
| MX315904B (es) | Inhibidores de fosfoinosituro-3 cinasa. | |
| PH12012500712A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
| HUE043522T2 (hu) | Bruton tirozinkináz inhibitorok | |
| IL225212A0 (en) | History of quinazoline–4 (h3)–ones used as pi3 kinase inhibitors | |
| PL2231642T3 (pl) | Pirymidyny jako inhibitory kinazy | |
| IL212755A0 (en) | Pyrazinopyrazines and derivatives as kinase inhibitors | |
| ZA201008283B (en) | Fumarate salt of 4-(3-chloro-2-fluoroanilino) -7-methoxy-6-{[1-(n-methylcarbamoylmethyl) piperidin-4-yl] oxy} quinazoline | |
| SG174893A1 (en) | Process for the preparation of 4-(3-chloro-2-fluoro-anilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)-piperidin-4-yl] oxy} quinazoline | |
| ZA201006135B (en) | Process for the manufacture of [phenylsufanylphenyl]piperidines | |
| ZA201000802B (en) | Process for the preparation of alfuzosin hydrochloride | |
| GB0914726D0 (en) | Kinase inhibitors | |
| EP2344472A4 (en) | ISOCHINOLINONDERIVATE | |
| HK1164285A (en) | Process for the preparation of 4-(3-chloro-2-fluoro-anilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)-piperidin- 4-yl]oxy}quinazoline | |
| GB0812609D0 (en) | Process for the preparation of deoxynojirimycin |